Expression of concern
Brk/Protein Tyrosine Kinase 6 Phosphorylates p27KIP1, Regulating the Activity of Cyclin D–Cyclin-Dependent Kinase 4
Paper Information
Record ID:
38657
Author(s):
Publication Date:
March 02, 2015
Retraction Date:
August 22, 2022
(3.2 years years ago)
Subjects:
Institutions:
- School of Graduate Studies, SUNY Downstate Medical Center, Brooklyn, New York, USA
- Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany
- Departments of Pediatrics and Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, USA
- College of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
- Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois, USA
Countries:
Article Type:
Publisher:
American Society for Microbiology
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1128/mcb.00322-22Citations (48)
48
Total Citations12
Post-Retraction(25.0%)
36
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
6
After 2+ years
1050
Days since retraction (latest)
CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors
E. Philip Horwitz, Taronish D. Dubash, Annamária Szabolcs et al. (20 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Jul 2025
1050 days after retraction
Dynamics Insights into CDK4/6-CyclinD1 Complex Stability Modulated by Abemaciclib
Yuqing Zhao, Zhuo Chen, Haoquan Liu et al. (7 authors)
Physical Chemistry Chemical Physics
Published: Jan 2025
863 days after retraction
Dual Inhibitors of <scp>CDK4</scp> /6 for Treating Cancer
Peter L. Toogood
Unknown Journal
Published: Dec 2024
858 days after retraction
Prognostic significance of p27 in colorectal cancer: a meta-analysis and bioinformatics analysis
Jing Zou, Dong Wang, Guobing Yin et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Dec 2024
854 days after retraction
Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinoma
Zizhou Niu, Zhichao Shi, Guoxiang Wu et al. (21 authors)
Bioorganic Chemistry
Published: Dec 2024
1 citation
1 citation
851 days after retraction
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): mechanisms of resistance and where to find them
Lorenzo Foffano, Linda Cucciniello, Eleonora Nicolò et al. (10 authors)
The Breast
Open Access
Published: Dec 2024
4 citations
4 citations
848 days after retraction
<i>CDKN1B</i>(p27<sup>kip1</sup>) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors
E. Philip Horwitz, Taronish D. Dubash, Annamária Szabolcs et al. (19 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2024
1 citation
1 citation
549 days after retraction
The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
Inês Gomes, Catarina Abreu, Luís Costa et al. (4 authors)
Cancers
Open Access
Published: Oct 2023
8 citations
8 citations
406 days after retraction
Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer
Samanta Jerin, Amanda Harvey, Annabelle Lewis
Cancers
Open Access
Published: Jul 2023
3 citations
3 citations
333 days after retraction
Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer
Samanta Jerin, Amanda Harvey, Annabelle Lewis
Unknown Journal
Open Access
Published: May 2023
3 citations
3 citations
276 days after retraction
A New Molecular (P)Layer in Pseudomyxoma Peritonei: The Splicing Machinery is Dysregulated and Linked to Low Survival
María Trinidad Moreno-Montilla, Emilia Alors‐Pérez, Ana Martínez-López et al. (15 authors)
Research Square (Research Square)
Open Access
Published: Dec 2022
106 days after retraction
Mechanisms of Resistance to CDK4/6 Inhibitors in Hormone Receptor-Positive (HR +) Breast Cancer: Spotlight on Convergent CDK6 Upregulation and Immune Signaling
Jamie O. Brett, Paige E. Herman, Erica L. Mayer et al. (5 authors)
Current Breast Cancer Reports
Published: Sep 2022
2 citations
2 citations
25 days after retraction
Combination Approaches to Target PD-1 Signaling in Cancer
Emily K. Moore, Marianne Strazza, Adam Mor
Frontiers in Immunology
Open Access
Published: Jul 2022
27 citations
27 citations
39 days before retraction
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review
Gian Luca Rampioni Vinciguerra, Maura Sonego, Ilenia Segatto et al. (7 authors)
Frontiers in Oncology
Open Access
Published: May 2022
34 citations
34 citations
87 days before retraction
Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation
Jacob B. Swadling, Tobias Warnecke, Kyle L. Morris et al. (4 authors)
Biophysical Journal
Open Access
Published: May 2022
13 citations
13 citations
89 days before retraction
Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression
Heidelinde Jäkel, Martin Taschler, Karin Jung et al. (10 authors)
Leukemia
Open Access
Published: May 2022
3 citations
3 citations
93 days before retraction
ACK1 upregulated the proliferation of head and neck squamous cell carcinoma cells by promoting p27 phosphorylation and degradation
Hsuan-Hsiang Peng, Hao-Chin Yang, Darius Rupa et al. (8 authors)
Journal of Cell Communication and Signaling
Open Access
Published: Mar 2022
5 citations
5 citations
170 days before retraction
CDK4 and CDK6 kinases: From basic science to cancer therapy
Anne Fassl, Yan Geng, Piotr Siciński
Science
Open Access
Published: Jan 2022
329 citations
329 citations
220 days before retraction
Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27
Katia Coulonval, Vincent Vercruysse, Sabine Paternot et al. (7 authors)
Cell Cycle
Open Access
Published: Dec 2021
10 citations
10 citations
249 days before retraction
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer
Gian Luca Rampioni Vinciguerra, Alessandra Dall’Acqua, Ilenia Segatto et al. (14 authors)
Cell Death and Disease
Open Access
Published: Oct 2021
10 citations
10 citations
311 days before retraction
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
Irina Jilishitz, Jason Luis Quiñones, Priyank Patel et al. (14 authors)
Molecular Cancer Research
Open Access
Published: Aug 2021
7 citations
7 citations
361 days before retraction
Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms
Bin Wang, Rui Li, Shuai Wu et al. (9 authors)
Frontiers in Oncology
Open Access
Published: May 2021
21 citations
21 citations
453 days before retraction
A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity
Sarah Nataraj, Stacy W. Blain
Cell Cycle
Open Access
Published: Apr 2021
2 citations
2 citations
507 days before retraction
Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors
Georgia Gomatou, Ioannis P. Trontzas, Stephanie Ioannou et al. (6 authors)
Molecular Biology Reports
Published: Jan 2021
31 citations
31 citations
598 days before retraction
A unified model for the G1/S cell cycle transition
Samuel Hume, Grigory L. Dianov, Kristijan Ramadan
Nucleic Acids Research
Open Access
Published: Oct 2020
150 citations
150 citations
677 days before retraction
Release from cell cycle arrest with Cdk4/6 inhibitors generates highly synchronized cell cycle progression in human cell culture
Eleanor W. Trotter, Iain Hagan
Open Biology
Open Access
Published: Oct 2020
42 citations
42 citations
690 days before retraction
Targeting protein tyrosine kinase 6 in cancer
Milica B. Gilic, Angela L. Tyner
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Open Access
Published: Sep 2020
30 citations
30 citations
703 days before retraction
Release from cell cycle arrest with Cdk4/6 inhibitors generates highly synchronised cell cycle progression in human cell culture
Eleanor W. Trotter, Iain Hagan
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2020
1 citation
1 citation
779 days before retraction
Molecular biology meets the endocrine pathologist: an appraisal of p27 in thyroid malignancy
Stephen M. Smith
Diagnostic histopathology
Published: Mar 2020
1 citation
1 citation
893 days before retraction
Protein tyrosine kinase 6 signaling in prostate cancer.
Wanian M Alwanian, Angela L. Tyner
PubMed
Published: Jan 2020
14 citations
14 citations
964 days before retraction
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
Scott Schoninger, Stacy W. Blain
Molecular Cancer Therapeutics
Open Access
Published: Jan 2020
81 citations
81 citations
964 days before retraction
Surprising regulation of cell cycle entry
Charles J. Sherr
Science
Published: Dec 2019
12 citations
12 citations
983 days before retraction
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Keelan Z. Guiley, Jack W. Stevenson, Kevin Lou et al. (12 authors)
Science
Open Access
Published: Dec 2019
198 citations
198 citations
983 days before retraction
Impact of endocrine disruptor hexachlorobenzene on the mammary gland and breast cancer: The story thus far
Noelia Miret, Carolina Pontillo, Lorena V. Zárate et al. (6 authors)
Environmental Research
Published: Mar 2019
59 citations
59 citations
1245 days before retraction
Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies
Yingjie Niu, Junnan Xu, Tao Sun
Journal of Cancer
Open Access
Published: Jan 2019
80 citations
80 citations
1329 days before retraction
Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Susan Gottesman, Jonathan Somma, Vladislav Tsiperson et al. (7 authors)
Molecular Cancer Research
Open Access
Published: Dec 2018
15 citations
15 citations
1344 days before retraction
Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells
Qilian He, Xingmei Nan, Silin Li et al. (8 authors)
BioMed Research International
Open Access
Published: Nov 2018
14 citations
14 citations
1363 days before retraction
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer
Cristina Guarducci, Martina Bonechi, Matteo Benelli et al. (13 authors)
npj Breast Cancer
Open Access
Published: Nov 2018
107 citations
107 citations
1369 days before retraction
Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells
Stacy W. Blain
Oncoscience
Open Access
Published: Jun 2018
3 citations
3 citations
1519 days before retraction
Role of p27Kip1 as a transcriptional regulator
Oriol Bachs, Edurne Gallastegui, Serena Orlando et al. (9 authors)
Oncotarget
Open Access
Published: May 2018
43 citations
43 citations
1550 days before retraction
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells
Priyank Patel, Vladislav Tsiperson, Susan Gottesman et al. (5 authors)
Molecular Cancer Research
Open Access
Published: Jan 2018
63 citations
63 citations
1682 days before retraction
Paper citing Brk/Protein Tyrosine Kinase 6 Phosphorylates p27(K...
Unknown Authors
Unknown Journal
Published: Jul 2017
1848 days before retraction
Cell-Cycle Therapeutics Come of Age
Matthew Ingham, Gary K. Schwartz
Journal of Clinical Oncology
Open Access
Published: Jun 2017
316 citations
316 citations
1906 days before retraction
FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27 <sup>Kip1</sup> in acute myeloid leukemia
Ines Peschel, Silvio Roland Podmirseg, Martin Taschler et al. (9 authors)
Haematologica
Open Access
Published: May 2017
21 citations
21 citations
1922 days before retraction
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response
Cristina Guarducci, Martina Bonechi, Giulia Boccalini et al. (8 authors)
Breast Care
Open Access
Published: Jan 2017
68 citations
68 citations
2059 days before retraction
Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art
Alessandro Del Gobbo, Stefano Ferrero
Gastroenterology Research and Practice
Open Access
Published: Jan 2017
4 citations
4 citations
2059 days before retraction
Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway
Guangzhi Wang, Mingna Liu, Hongjun Wang et al. (12 authors)
Journal of Cancer
Open Access
Published: Jan 2016
38 citations
38 citations
2425 days before retraction
Tracing the footprints of the breast cancer oncogene BRK — Past till present
Raghuveera Kumar Goel, Kiven Erique Lukong
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: May 2015
38 citations
38 citations
2653 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #46264
Feb 27, 2023Quick Stats
Total Citations:
48
Years Since Retraction:
3.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025